GSK 3277511AAlternative Names: GSK3277511; GSK3277511A; NTHi/Mcat-vaccine
Latest Information Update: 19 Sep 2015
At a glance
- Originator GlaxoSmithKline
- Class Vaccines
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Respiratory tract disorders
Most Recent Events
- 01 Aug 2015 Phase-I clinical trials in Respiratory tract disorders (Prevention) in Belgium (IM)